{"organizations": [], "uuid": "81dcd1ee5faf4607c9569d53d8a3da8799e08bd2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "//sc.cnbcfm.com/applications/cnbc.com/staticcontent/img/cnbc_logo.gif", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/01/03/pr-newswire-cvs-health-to-hold-earnings-guidance-conference-call.html", "country": "US", "domain_rank": 767, "title": "CVS Health to Hold Earnings Guidance Conference Call", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.018, "site_type": "news", "published": "2018-01-04T06:01:00.000+02:00", "replies_count": 0, "uuid": "81dcd1ee5faf4607c9569d53d8a3da8799e08bd2"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/01/03/pr-newswire-cvs-health-to-hold-earnings-guidance-conference-call.html", "ord_in_thread": 0, "title": "CVS Health to Hold Earnings Guidance Conference Call", "locations": [], "entities": {"persons": [], "locations": [{"name": "r.i.", "sentiment": "none"}, {"name": "woonsocket", "sentiment": "none"}], "organizations": [{"name": "cvs health corporation", "sentiment": "negative"}, {"name": "cvs", "sentiment": "negative"}, {"name": "cvs health", "sentiment": "negative"}, {"name": "nyse", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WOONSOCKET, R.I., Jan. 3, 2018 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) announced today it will hold a conference call to discuss its 2017 and 2018 earnings guidance tomorrow, Thursday, January 4, 2018, at 11:00 a.m. ET. In order to be responsive to investor desire for additional insight and given the company's forthcoming acquisition-related Form S-4 filing, the company intends to provide the market with its expectations in advance of its fourth quarter earnings call in early February.\nAn audio webcast of the call will be broadcast simultaneously for all interested parties through the Investor Relations section of the CVS Health website at http://investors.cvshealth.com . This webcast will be archived and available on the website for a one-year period following the conference call.\nAbout the Company\nCVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at https://www.cvshealth.com .\nNo Offer or Solicitation\nThis communication is for informational purposes only and not intended to and does not constitute an offer to subscribe for, buy or sell, the solicitation of an offer to subscribe for, buy or sell or an invitation to subscribe for, buy or sell any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.\nAdditional Information and Where to Find It\nIn connection with the proposed transaction between CVS Health Corporation (\"CVS Health\") and Aetna Inc. (\"Aetna\"), CVS Health and Aetna will file relevant materials with the Securities and Exchange Commission (the \"SEC\"), including a CVS Health registration statement on Form S-4 that will include a joint proxy statement of CVS Health and Aetna that also constitutes a prospectus of CVS Health, and a definitive joint proxy statement/prospectus will be mailed to stockholders of CVS Health and shareholders of Aetna. INVESTORS AND SECURITY HOLDERS OF CVS HEALTH AND AETNA ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the registration statement and the joint proxy statement/prospectus (when available) and other documents filed with the SEC by CVS Health or Aetna through the website maintained by the SEC at http://www.sec.gov . Copies of the documents filed with the SEC by CVS Health will be available free of charge within the Investors section of CVS Health's Web site at http://www.cvshealth.com/investors or by contacting CVS Health's Investor Relations Department at 800-201-0938. Copies of the documents filed with the SEC by Aetna will be available free of charge on Aetna's internet website at http://www.Aetna.com or by contacting Aetna's Investor Relations Department at 860-273-8204.\nParticipants in Solicitation\nCVS Health, Aetna, their respective directors and certain of their respective executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of CVS Health is set forth in its Annual Report on Form 10-K for the year ended December 31, 2016 (\"CVS Health's Annual Report\"), which was filed with the SEC on February 9, 2017, its proxy statement for its 2017 annual meeting of stockholders, which was filed with the SEC on March 31, 2017, and its Current Report on Form 8-K, which was filed with the SEC on May 12, 2017. Information about the directors and executive officers of Aetna is set forth in its Annual Report on Form 10-K for the year ended December 31, 2016 (\"Aetna's Annual Report\"), which was filed with the SEC on February 17, 2017, its proxy statement for its 2017 annual meeting of shareholders, which was filed with the SEC on April 7, 2017, and its Current Reports on Form 8-K, which were filed with the SEC on May 24, 2017 and October 2, 2017. Other information regarding the participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available.\nCautionary Statement Regarding Forward-Looking Statements\nThe Private Securities Litigation Reform Act of 1995 (the \"Reform Act\") provides a safe harbor for forward-looking statements made by or on behalf of CVS Health or Aetna. This communication may contain forward-looking statements within the meaning of the Reform Act. You can generally identify forward-looking statements by the use of forward-looking terminology such as \"anticipate,\" \"believe,\" \"can,\" \"continue,\" \"could,\" \"estimate,\" \"evaluate,\" \"expect,\" \"explore,\" \"forecast,\" \"guidance,\" \"intend,\" \"likely,\" \"may,\" \"might,\" \"outlook,\" \"plan,\" \"potential,\" \"predict,\" \"probable,\" \"project,\" \"seek,\" \"should,\" \"view,\" or \"will,\" or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond CVS Health's and Aetna's control.\nStatements in this communication regarding CVS Health and Aetna that are forward-looking, including CVS Health's and Aetna's projections as to the closing date for the pending acquisition of Aetna (the \"transaction\"), the extent of, and the time necessary to obtain, the regulatory approvals required for the transaction, the anticipated benefits of the transaction, the impact of the transaction on CVS Health's and Aetna's businesses, the expected terms and scope of the expected financing for the transaction, the ownership percentages of CVS Health's common stock of CVS Health stockholders and Aetna shareholders at closing, the aggregate amount of indebtedness of CVS Health following the closing of the transaction, CVS", "external_links": ["http://investors.cvshealth.com/", "http://www.cvshealth.com/investors", "http://www.prnewswire.com/news-releases/cvs-health-to-hold-earnings-guidance-conference-call-300577443.html", "https://www.cvshealth.com/"], "published": "2018-01-04T06:01:00.000+02:00", "crawled": "2018-01-04T07:15:49.009+02:00", "highlightTitle": ""}